인쇄하기
취소

KFDA reviews generic raw materials of Joins

Published: 2010-02-04 06:57:00
Updated: 2010-02-04 06:57:00
The Korea Food and Drug Administration has begun to review raw materials and manufacturing process of Joins generics in four manufacturing sites from last week, a source said recently. Joins is an arthritis drug developed by SK Chemicals Co.

The KFDA review group conducted an on-the-spot inspection of the four production sites and said it will adopt a rigorous inspection standard of herbal s...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.